Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.Journal of Clinical Pharmacology|April 1, 1995
The pharmacokinetics of venlafaxine when given in a twice-daily regimenS M Troy, V D Parker, R J Fruncillo, et al.Clinical Pharmacology and Therapeutics|March 1, 1992
The effect of renal disease on tolrestat pharmacokineticsS M Troy, D R Hicks, M Kraml, et al.Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanolS M Troy, M B Turner, M Unruh, et al.Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.Clinical Pharmacology and Therapeutics|July 1, 1994
The effect of renal disease on the disposition of venlafaxineS M Troy, R W Schultz, V D Parker, et al.Journal of Clinical Pharmacology|April 1, 1995
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepamS M Troy, I Lucki, A A Peirgies, et al.Journal of Clinical Pharmacology|May 29, 1998
The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxineS M Troy, R Rudolph, M Mayersohn, et al.Pharmacotherapy|September 1, 1996
Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokineticsK J Klamerus, V D Parker, R L Rudolph, et al.Journal of Clinical Pharmacology|May 1, 1991
The absolute bioavailability and dose proportionality of intravenous and oral dosage regimens of recainamS M Troy, W H Cevallos, K A Conrad, et al.Pageof 10